期刊文献+

棓丙酯治疗急性心肌梗死疗效观察 被引量:2

Curative Effect Observation of Propyl Gallate Injection in the Treatment of Patients with Acute Myocardial Infarction
下载PDF
导出
摘要 目的:观察丙酯注射液治疗接受直接经皮冠状动脉介入治疗(PCI)后的急性心肌梗死患者的临床疗效,探讨应用丙酯注射液是否减少不良心脏事件的发生及药物本身的安全性。方法:纳入78例诊断为急性ST段抬高型心肌梗死并行急诊PCI的患者,随机分为观察组与对照组(观察组43例,对照组35例)。所有患者术前给予常规处置及治疗,观察组于术后应用丙酯注射液120 mg,加入0.9%氯化钠溶液250 m L静脉点滴,1 d 1次,疗程为10 d。术前及术后24 h检查心肌损伤标志物肌钙蛋白T,于术前、术后24 h、术后2 d及出院前检测血清磷酸肌酸激酶同工酶CK-MB的指标,主要观察直接PCI后的患者应用丙酯注射液治疗后的疗效。随访期为6个月,记录患者在术后当日至术后6个月期间不良心脏事件的发生率(包括全因死亡、非致死性心肌梗死、靶血管再次血运重建)及出血等并发症。结果:急性ST段抬高型心肌梗死患者急诊PCI后心肌损伤标志物均有不同程度的升高(P<0.01)。应用丙酯注射液治疗的患者临床疗效显效性优于对照组(P<0.05)。对照组死亡1例,观察组非致死性心肌梗死1例,两组患者半年内无出血等不良反应的发生,两组相比差异无统计学意义(P>0.05)。结论:丙酯治疗急诊心肌梗死患者安全有效。 Objective:To observe the clinical effect of propyl gallate injection in the treatment of patients with acute myocardial infarction.This study discusses whether the application of propyl gallate injection can reduce adverse cardiac events and other adverse reactions,and investigate the safety of propyl gallate. Method:A total of 78 patients with acute myocardial infarction were randomly divided into two group(the study group:n=43;the control group:n=35).All patients were given conventional treatment before PCI.The study group in postoperative was applied of propyl gallate injection 120 mg+0.9% Sodium Chloride Solution 250 m L,intravenous drip,once a day(QD),10 days for a course. Before PCI,24 h after PCI,the levels of cardiac markers-cardiac troponin T were detected. Levels of cardiac markers-creatine kinase-MB were determined before the treatment,24 h after operation,2 days after the operation and before discharge.The main outcome PCI postoperative propyl gallate injection therapy enhanced the efficacy.Patients were followed up for six months,records of the patients in the postoperative adverse cardiac events during the day to half a year(including the incidence of all-cause mortality,nonfatal myocardial infarction,target vessel revascularization)and hemorrhage. Results:Myocardial injury markers was increased with the emergency treatment of acute myocardial infarction after PCI.The clinical effect of patients with application of propyl gallate injection was better than that of control group(P〈0.01).The control group has one cases of death,the study group has one patient who died of nonfatal myocardial infarction(P〈0.05).No adverse reactions such as bleeding of the two groups of patients within six months(P〉0.05).Conclusion:Propyl gallate treatment in patients with acute myocardial infarction was effective and safety.
作者 马蕊 王耿
机构地区 沈阳军区总医院
出处 《辽宁中医药大学学报》 CAS 2015年第9期162-165,共4页 Journal of Liaoning University of Traditional Chinese Medicine
关键词 丙酯 急性心肌梗死 疗效 安全性 propyl gallate acute myocardial infarction efficacy safety
  • 相关文献

参考文献19

  • 1陆再英,钟南山.内科学[M].北京:人民卫生出版社,2008:121.
  • 2Santoro GM,Carrabba N,Migliorini A,et al.Acute heart failure in patients with acute myocardial infarction treated with primary percutaneous coronary intervention[J].Eur J Heart Fail,2008,10:780-785.
  • 3Keeley EC,Boura JA,Grines CL.Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction:aquantitative review of 23 randomised trials[J].Lancet,2003,361(9351):13-20.
  • 4Pfosker GL,Lysang-Williams KA.Clopidogrel:a review of its use in the prevention of thrombosis[J].Drugs,2007,67(4):613-646.
  • 5Li J,Jian Z,Song M,et al.Tailored antiplatelet therapy and clinical adverse outcomes[J].Heart,2014,100(1):41-46.
  • 6Bergovec M,Vrazi C H,Rajcan Spoljari C I,et al.Features and pathophysiology of acute coronary syndrome[J].Acta Med Croatica,2009,63(1):3-7.
  • 7Hong YJ,Jeong MH,Choi YH,et al.Predictors of no-reflow after percutaneous coronary intervention for culprit lesion with plaque rupture in infarct-related artery in patients with acute myocardial infarction[J].J Cardiol,2009,54(1):36-44.
  • 8张步春,徐亚伟.心血管介入治疗后血栓的防治[J].中国实用内科杂志,2010,30(7):596-598. 被引量:5
  • 9Gravning J,Ueland T,Morkrid L,et al.Different prognostic importance of elevated troponin I after percutaneous coronary intervention in acute coronary syndrome and stable angina pectoris[J].Scand Cardiovasc J,2008,42(3):214-221.
  • 10Prasad A,Singh M,Lerman A,et al.Isolated elevation in troponin T after percutaneous coronary intervention is associated with higher long-term mortality[J].J Am Coll Cardiol,2006,48(9):1765-1770.

二级参考文献65

  • 1王国平,郑旭.非甾体抗炎药相关性上消化道出血的临床特点[J].海峡药学,2004,16(5):106-108. 被引量:13
  • 2马娟,元刚,陈旻湖.非甾体类消炎药对胃黏膜的损伤及替普瑞酮预防作用的实验研究[J].中华医学杂志,2006,86(40):2868-2873. 被引量:12
  • 3吕树铮,宋现涛,陈韵岱,陈欣,中国经皮冠状动脉介入治疗登记调查研究协作组.中国大陆2005年度经皮冠状动脉介入治疗登记调查研究结果初步分析[J].中华心血管病杂志,2006,34(11):966-970. 被引量:43
  • 4栾好波.非甾体类抗炎药物对胃肠道损伤机制及预防[J].齐鲁药事,2007,26(5):297-299. 被引量:8
  • 5Serebruany VL,Steinhubi SR,Berger PB,et al.Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials.Am J Cardio1,2005,95:1218-1222.
  • 6Walker J,Robinson J,Stewart J,et al.Does enteric-ccated aspirin result in a lower incidence of gastrointestinal complications compared to normal aspirin? Interact Cardiovasc Thorac Stag,2007,6:519-522.
  • 7Kelly JP,Kanfman DW,Jurgelon JM,et al.Risk of aspirinassociated major upper-gastrointestinal bleeding with enteric-coated or buffered product.Lancet,1996,348:1413-1416.
  • 8Hemandez-Diaz S,Garcia Rodriguez LA.Cardioprotective aspirin users and their excess risk of upper gastrointestinal complications.BMC Med,2006,4:22.
  • 9Taha AS,Angerson WJ,Prnsad R,et al.Clinical trial:the incidence and early mortality after peptic ulcer perforation,and the use of low-dose aspirin and nonsteroidal anti-inflammatory drugs.Aliment Pharmacol Ther,2008,28:878-885.
  • 10Papatheodoridis GV,Sougioultzis S,Archimandrifis AJ.Effcts of Helicobacter pylori and nonsteroidal anti-inflammatery drugs on peptic ulcer disease:a systematic review.Clin Gastroenterol Hepatol,2006,4:130-142.

共引文献2459

同被引文献23

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部